Key result
Metabolic syndrome linked to ~40% greater risk of LVDD and impaired GLS.
Why the study?
The study was conducted to explore the association of metabolic syndrome with left ventricular diastolic and systolic dysfunction, and evaluate additive and multiplicative interactions among age, sex, obesity, and metabolic syndrome.
Is metabolic syndrome associated with left ventricular diastolic and systolic dysfunction, and are there additive interactions with age, sex, and obesity?
Cohort (n=5,503)
Yes
Is metabolic syndrome associated with left ventricular diastolic and systolic dysfunction, and are there additive interactions with age, sex, and obesity?
Metabolic syndrome is independently associated with left ventricular diastolic and systolic dysfunction, with synergistic detrimental effects observed in women, the elderly, and obese individuals.
Metabolic syndrome was associated with subclinical LV dysfunction; hypothesis-generating for additive interactions with age, sex, and obesity.
OBJECTIVE: This study aims to explore the association between metabolic syndrome (MetS) and left ventricular diastolic dysfunction (LVDD) and systolic dysfunction (LVSD), defined by impaired global longitudinal strain (GLS), and assess additive and multiplicative interactions among age, sex, obesity, and MetS regarding LVDD and LVSD. METHODS: We prospectively recruited 5503 participants from the China PEACE (Patient-Centered Evaluative Assessment of Cardiac Events) Million Persons Project with complete echocardiography exam. Multivariable logistic models were used to calculate adjusted odds ratios to evaluate both additive and multiplicative interactions. RESULTS: The mean age was 56.59 years; 59.4% were women, 46.7% had MetS, 26.6% had left ventricular hypertrophy, 46.3% had LVDD, and 12.50% had impaired GLS. Compared to the non-MetS, the odds ratio (OR) of LVDD and impaired GLS in MetS were 1.40 (1.20-1.64) and 1.26 (1.03-1.54), respectively. For LVDD, relative excess risk due to additive interaction (RERI) for women and MetS, elderly and MetS, obesity and MetS were 0.76 (0.02-1.50), 35.65 (17.51-53.79), and 2.14 (0.66-3.62), respectively, thus suggesting additive interactions. For impaired GLS, RERI for obesity and MetS was 3.37 (0.50-6.24), thus suggesting additive interactions. CONCLUSIONS: The MetS is independently associated with LVDD and impaired GLS. From the public health implications, prevention of MetS in women, elderly, and obese individuals might result in a greater reduction of LVDD and LVSD risk in cardiovascular high-risk population.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2023) conducted a cohort in Metabolic syndrome and left ventricular dysfunction (n=5,503). Metabolic syndrome vs. Non-metabolic syndrome was evaluated on Left ventricular diastolic dysfunction (LVDD) (OR 1.40, 95% CI 1.20-1.64). Metabolic syndrome was independently associated with left ventricular diastolic dysfunction (OR 1.40; 95% CI 1.20-1.64) and impaired global longitudinal strain (OR 1.26; 95% CI 1.03-1.54).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: